Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

8-K filing — PMGC Holdings Inc. (ELAB)

Filed: 2026-09-02 AccNo: 0001213900-26-096784 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

PMGC Holdings’ Northstrive Amends Development And License Agreement With Yuva Biosciences To Launch Three-Phase Program Advancing Four AI-Discovered Compounds And Updating AI Scope, IP, Field Of Use, And Financial Terms

Building on positive Phase III results from the parties' AI-driven drug discovery program, the six-month Expansion Program will narrow the four validated compounds toward a nominated lead and designated backup.The

PMGC Holdings Announces Non-Binding Term Sheet With Orbit2Orbit Covering Microgravity Mice Study Of EL-22 And EL-32, Preferred U.S. Manufacturing Role For A&B Aerospace, And CAD 200K Investment

PMGC Holdings' NorthStrive Biosciences Announces Two U.S. Patent Applications Covering EL-22 And EL-32 For Preserving Muscle Mass During Microgravity Exposure